Back to search

Mild Decreases in White Blood Cell and Platelet Counts Are Present One Year After Radioactive Iodine Remnant Ablation

Data up to Jan 2025

Published2009
Citations44
References15

Total Citations Per Year

Abstract

References (15)

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

2006 • 2,021 citations

Second primary malignancies in thyroid cancer patients

2003 • 623 citations

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.

1962 • 441 citations

The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer

2007 • 366 citations

Radioactive Iodine and the Salivary Glands

2003 • 359 citations

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

2006 • 325 citations

Nasolacrimal Drainage System Obstruction from Radioactive Iodine Therapy for Thyroid Carcinoma

2002 • 169 citations

A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.

2002 • 146 citations

Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal

2008 • 141 citations

Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity

2008 • 104 citations

rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.

2003 • 81 citations

Hematologic changes observed following I-131 therapy for thyroid carcinoma.

1963 • 28 citations

Gonadal function in patients with differentiated thyroid cancer treated with (131)I.

2006 • 24 citations

Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience

2005 • 23 citations

Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man

1989 • 23 citations

Cited By (0)

No citing papers found in database

Mild Decreases in White Blood Cell and Platelet Counts Are Present One Year After… (2009) – Thyroid | Metascience Observatory Explorer